Innoviva (INVA) Equity Income (2022 - 2026)
Powered by 
Analysis
Innoviva (INVA) Equity Income (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 4.08 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Innoviva | 1.56 Bn | 977.47 Mn | 90.62 Mn | -131.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -131.83 Mn |
| Mar 31, 2026 | 157.65 Mn |
| Sep 30, 2025 | 30.75 Mn |
| Jun 30, 2025 | 13.08 Mn |
| Mar 31, 2025 | -13.55 Mn |
| Sep 30, 2024 | -43.00 Mn |
| Jun 30, 2024 | -60.11 Mn |
| Mar 31, 2024 | 35.34 Mn |
| Sep 30, 2023 | 71.98 Mn |
| Jun 30, 2023 | -19.91 Mn |
| Mar 31, 2023 | 15.82 Mn |
| Sep 30, 2022 | -44.48 Mn |
| Jun 30, 2022 | -42.82 Mn |
| Mar 31, 2022 | -11.95 Mn |